138 related articles for article (PubMed ID: 34695709)
1. Histamine H
Falkenstein M; Reiner-Link D; Zivkovic A; Gering I; Willbold D; Stark H
Bioorg Med Chem; 2021 Nov; 50():116462. PubMed ID: 34695709
[TBL] [Abstract][Full Text] [Related]
2. Optimization and preclinical evaluation of novel histamine H
Szczepańska K; Karcz T; Kotańska M; Siwek A; Kuder KJ; Latacz G; Mogilski S; Hagenow S; Lubelska A; Sobolewski M; Stark H; Kieć-Kononowicz K
Bioorg Med Chem; 2018 Dec; 26(23-24):6056-6066. PubMed ID: 30448256
[TBL] [Abstract][Full Text] [Related]
3. Structural modifications in the distal, regulatory region of histamine H
Szczepańska K; Pockes S; Podlewska S; Höring C; Mika K; Latacz G; Bednarski M; Siwek A; Karcz T; Nagl M; Bresinsky M; Mönnich D; Seibel U; Kuder KJ; Kotańska M; Stark H; Elz S; Kieć-Kononowicz K
Eur J Med Chem; 2021 Mar; 213():113041. PubMed ID: 33261900
[TBL] [Abstract][Full Text] [Related]
4. Search for new multi-target compounds against Alzheimer's disease among histamine H
Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851
[TBL] [Abstract][Full Text] [Related]
5. Identification of N-phenyl-3-methoxy-4-pyridinones as orally bioavailable H
Zhang M; Tang L; Jiang L; Wei J; Hu Y; Sheng R
Eur J Med Chem; 2021 Feb; 212():113096. PubMed ID: 33395621
[TBL] [Abstract][Full Text] [Related]
6. N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H
Szczepańska K; Kincses A; Vincze K; Szymańska E; Latacz G; Kuder KJ; Stark H; Spengler G; Handzlik J; Kieć-Kononowicz K
Bioorg Med Chem Lett; 2020 Nov; 30(22):127522. PubMed ID: 32871268
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H
Szczepańska K; Karcz T; Mogilski S; Siwek A; Kuder KJ; Latacz G; Kubacka M; Hagenow S; Lubelska A; Olejarz A; Kotańska M; Sadek B; Stark H; Kieć-Kononowicz K
Eur J Med Chem; 2018 May; 152():223-234. PubMed ID: 29723785
[TBL] [Abstract][Full Text] [Related]
8. New lead elements for histamine H
Espinosa-Bustos C; Frank A; Arancibia-Opazo S; Salas CO; Fierro A; Stark H
Bioorg Med Chem Lett; 2018 Sep; 28(17):2890-2893. PubMed ID: 30025902
[TBL] [Abstract][Full Text] [Related]
9. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H
Szczepańska K; Podlewska S; Dichiara M; Gentile D; Patamia V; Rosier N; Mönnich D; Ruiz Cantero MC; Karcz T; Łażewska D; Siwek A; Pockes S; Cobos EJ; Marrazzo A; Stark H; Rescifina A; Bojarski AJ; Amata E; Kieć-Kononowicz K
ACS Chem Neurosci; 2022 Jan; 13(1):1-15. PubMed ID: 34908391
[TBL] [Abstract][Full Text] [Related]
10. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.
Sadek B; Schwed JS; Subramanian D; Weizel L; Walter M; Adem A; Stark H
Eur J Med Chem; 2014 Apr; 77():269-79. PubMed ID: 24650714
[TBL] [Abstract][Full Text] [Related]
11. A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine H
Rosier N; Grätz L; Schihada H; Möller J; Işbilir A; Humphrys LJ; Nagl M; Seibel U; Lohse MJ; Pockes S
J Med Chem; 2021 Aug; 64(15):11695-11708. PubMed ID: 34309390
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Potential, Dual-Active Histamine H
Kuder KJ; Kotańska M; Szczepańska K; Mika K; Reiner-Link D; Stark H; Kieć-Kononowicz K
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921144
[TBL] [Abstract][Full Text] [Related]
13. Non-Imidazole Histamine H3 Ligands. Part VI. Synthesis and Preliminary Pharmacological Investigation of Thiazole-Type Histamine H3-Receptor Antagonists with Lacking a Nitrogen Nucleus in the Side Chain.
Guryn R; Staszewski M; Kopczacki P; Walczyski K
Med Chem; 2016; 13(1):65-76. PubMed ID: 27220560
[TBL] [Abstract][Full Text] [Related]
14. Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs.
Lipani L; Odadzic D; Weizel L; Schwed JS; Sadek B; Stark H
Eur J Med Chem; 2014 Oct; 86():578-88. PubMed ID: 25218907
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel steroidal histamine H
Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Greiner I; Schmidt É; Némethy Z; Kedves RS; Balázs O; Román V; Lévay G; Mahó S
Bioorg Med Chem Lett; 2017 Oct; 27(19):4525-4530. PubMed ID: 28888822
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity.
Kuder KJ; Stachnik M; Schunack W; Szymańska E; Kieć-Kononowicz K
Med Chem; 2014; 10(6):588-99. PubMed ID: 24047214
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists.
Zeng Q; Rosenblum SB; Yang Z; Jiang Y; McCormick KD; Aslanian RG; Duguma L; Kozlowski JA; Shih NY; Hey JA; West RE; Korfmacher WA; Berlin M; Boyce CW
Bioorg Med Chem Lett; 2013 Nov; 23(21):6001-3. PubMed ID: 24050887
[TBL] [Abstract][Full Text] [Related]
18. Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.
Huang W; Tang L; Shi Y; Huang S; Xu L; Sheng R; Wu P; Li J; Zhou N; Hu Y
Bioorg Med Chem; 2011 Dec; 19(23):7158-67. PubMed ID: 22019465
[TBL] [Abstract][Full Text] [Related]
19. The discovery of quinoline based single-ligand human H
Procopiou PA; Ancliff RA; Gore PM; Hancock AP; Hodgson ST; Holmes DS; Keeling SP; Looker BE; Parr NA; Rowedder JE; Slack RJ
Bioorg Med Chem Lett; 2016 Dec; 26(24):5855-5859. PubMed ID: 27866818
[TBL] [Abstract][Full Text] [Related]
20. Rasagiline derivatives combined with histamine H
Lutsenko K; Hagenow S; Affini A; Reiner D; Stark H
Bioorg Med Chem Lett; 2019 Oct; 29(19):126612. PubMed ID: 31421966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
